Use of SIP1 As Determinant of Breast Cancer Stemness

The present invention relates to the diagnosis and treatment of cancer. More specifically, it relates to the use of SIP1 nucleic acid and/or protein for the detection of breast cancer stem cells, and the repression of the gene and/or the inactivation of the protein to repress the differentiation of cells into cancer cells and to inhibit metastasis of breast cancer tumors.

Attached files:


Patents:
US 20,110,104,183   [MORE INFO]

Inventor(s): BERX GEERT [BE]; VANDEWALLE CINDY [BE]; RASPE ERIC [BE]

Type of Offer: Sale



« More Medical Patents

---